Lung Diseases

The supplied grounding does not support a single cause for lung diseases because it is a broad category rather than one disorder. The literature indicates that etiology varies by condition and may include infectious causes, immune-mediated processes, and age-associated biological changes. Postacute sequelae after SARS-CoV-2 infection are also covered as one disease-related context.

The grounding supports several mechanisms relevant to lung disease, including aging and cellular senescence. Aging of the lung is associated with molecular and physiological changes that alter lung function, reduce pulmonary remodeling and regenerative capacity, and increase susceptibility to acute and chronic disease. The literature also points to altered interactions between pulmonary resident cells and systemic immune cells, as well as immune dysregulation in some lung-related conditions.

Older age is supported as a risk factor because natural lung aging is associated with increased susceptibility to infection and chronic lung disease. The grounding also indicates that risk varies by disease subtype and may depend on factors such as infection-related exposures and immune status. No broader unified risk profile is supported for all lung diseases.

The supplied grounding does not support a single standard of care for all lung diseases because treatment depends on the specific underlying condition. The literature only supports that drug therapy is one of the covered management areas, and that diagnosis and clinical monitoring are important components of care. For chronic lung disease assessment, chest electrical impedance tomography is described as a clinical tool for monitoring regional lung ventilation and pulmonary function.